Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of CareDx, Inc. from Q4 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
CareDx, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q4 2013 to Q3 2023.
  • CareDx, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2023 was $394,134,000, a 9.74% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

CareDx, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $394,134,000 -$42,545,000 -9.7% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $405,213,000 -$38,336,000 -8.6% 30 Jun 2023 10-Q 08 Nov 2023 2023 Q3
Q1 2023 $420,021,000 -$37,523,000 -8.2% 31 Mar 2023 10-Q 08 Nov 2023 2023 Q3
Q4 2022 $430,911,000 -$34,965,000 -7.5% 31 Dec 2022 10-Q 08 Nov 2023 2023 Q3
Q3 2022 $436,679,000 -$35,468,000 -7.5% 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $443,549,000 -$36,294,000 -7.6% 30 Jun 2022 10-Q 08 Nov 2023 2023 Q3
Q1 2022 $457,544,000 -$14,002,000 -3% 31 Mar 2022 10-Q 08 Nov 2023 2023 Q3
Q4 2021 $465,876,000 +$188,197,000 +68% 31 Dec 2021 10-Q 08 Nov 2023 2023 Q3
Q3 2021 $472,147,000 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $479,843,000 30 Jun 2021 10-Q 03 Nov 2022 2022 Q3
Q1 2021 $471,546,000 31 Mar 2021 10-Q 03 Nov 2022 2022 Q3
Q4 2020 $277,679,000 +$178,679,000 +180% 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q4 2019 $99,000,000 +$3,072,000 +3.2% 31 Dec 2019 10-K 27 Feb 2023 2022 FY
Q3 2019 $97,543,000 +$53,155,000 +120% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $93,166,000 +$64,214,000 +222% 30 Jun 2019 10-Q 31 Oct 2019 2019 Q3
Q1 2019 $95,622,000 +$62,230,000 +186% 31 Mar 2019 10-Q 31 Oct 2019 2019 Q3
Q4 2018 $95,928,000 +$101,882,000 31 Dec 2018 10-K 24 Feb 2022 2021 FY
Q3 2018 $44,388,000 +$44,563,000 30 Sep 2018 10-Q 31 Oct 2019 2019 Q3
Q2 2018 $28,952,000 +$16,966,000 +142% 30 Jun 2018 10-Q 31 Oct 2019 2019 Q3
Q1 2018 $33,392,000 +$18,532,000 +125% 31 Mar 2018 10-Q 31 Oct 2019 2019 Q3
Q4 2017 $-5,954,000 -$25,715,000 -130% 31 Dec 2017 10-K 24 Feb 2021 2020 FY
Q3 2017 $-175,000* -$36,955,000 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $11,986,000 -$20,524,000 -63% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 $14,860,000 31 Mar 2017 10-Q 09 Jun 2017 2017 Q1
Q4 2016 $19,761,000 -$9,733,000 -33% 31 Dec 2016 10-K 28 Feb 2020 2019 FY
Q3 2016 $36,780,000 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $32,510,000 30 Jun 2016 10-Q 22 Aug 2016 2016 Q2
Q4 2015 $29,494,000 -$11,802,000 -29% 31 Dec 2015 10-K 06 Mar 2019 2018 FY
Q4 2014 $41,296,000 +$191,971,000 31 Dec 2014 10-K 22 Mar 2018 2017 FY
Q4 2013 $-150,675,000 31 Dec 2013 10-K 21 Apr 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.